Pantothenate kinase 4 controls skeletal muscle substrate metabolism

A Adriana Miranda-Cervantes A Andreas M. Fritzen S Steffen H. Raun O Ondřej Hodek L Lisbeth L. V. Møller K Kornelia Johann L Luisa Deisen P Paul Gregorevic A Anders Gudiksen A Anna Artati J Jerzy Adamski N Nicoline R. Andersen C Casper M. Sigvardsen C Christian S. Carl C Christian T. Voldstedlund R Rasmus Kjøbsted S Stefanie M. Hauck (Metabolomics and Proteomics Core, Helmholtz Centre Munich, German Research Center for Environmental Health, Neuherberg, Germany.) P Peter Schjerling T Thomas E. Jensen A Alberto Cebrian-Serrano M Markus Jähnert P Pascal Gottmann I Ingo Burtscher H Heiko Lickert H Henriette Pilegaard A Annette Schürmann M Matthias H. Tschöp T Thomas Moritz (Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen) T Timo D. Müller L Lykke Sylow B Bente Kiens E Erik A. Richter M Maximilian Kleinert

Abstract

AbstractMetabolic flexibility in skeletal muscle is essential for maintaining healthy glucose and lipid metabolism, and its dysfunction is closely linked to metabolic diseases. Exercise enhances metabolic flexibility, making it an important tool for discovering mechanisms that promote metabolic health. Here we show that pantothenate kinase 4 (PanK4) is a new conserved exercise target with high abundance in muscle. Muscle-specific deletion of PanK4 impairs fatty acid oxidation which is related to higher intramuscular acetyl-CoA and malonyl-CoA levels. Elevated acetyl-CoA levels persist regardless of feeding state and are associated with whole-body glucose intolerance, reduced insulin-stimulated glucose uptake in glycolytic muscle, and impaired glucose uptake during exercise. Conversely, increasing PanK4 levels in glycolytic muscle lowers acetyl-CoA and enhances glucose uptake. Our findings highlight PanK4 as an important regulator of acetyl-CoA levels, playing a key role in both muscle lipid and glucose metabolism.

Article Details

Volume / Issue Vol. 16, Issue 1
Published January 02, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (33)

A

Adriana Miranda-Cervantes

A

Andreas M. Fritzen

S

Steffen H. Raun

O

Ondřej Hodek

L

Lisbeth L. V. Møller

K

Kornelia Johann

L

Luisa Deisen

P

Paul Gregorevic

A

Anders Gudiksen

A

Anna Artati

J

Jerzy Adamski

N

Nicoline R. Andersen

C

Casper M. Sigvardsen

C

Christian S. Carl

C

Christian T. Voldstedlund

R

Rasmus Kjøbsted

S

Stefanie M. Hauck

Metabolomics and Proteomics Core, Helmholtz Centre Munich, German Research Center for Environmental Health, Neuherberg, Germany.

P

Peter Schjerling

T

Thomas E. Jensen

A

Alberto Cebrian-Serrano

M

Markus Jähnert

P

Pascal Gottmann

I

Ingo Burtscher

H

Heiko Lickert

H

Henriette Pilegaard

A

Annette Schürmann

M

Matthias H. Tschöp

T

Thomas Moritz

Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen

T

Timo D. Müller

L

Lykke Sylow

B

Bente Kiens

E

Erik A. Richter

M

Maximilian Kleinert